The TRAIL to selective tumor death

Nature Medicine

Volumn 5, Issue 2, 1999, Pages 146-147

  French, Lars E ^a   Tschopp, Jürg ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIGAND; PROTEIN P53; TUMOR NECROSIS FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; COLON CARCINOMA; GENE INDUCTION; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032962163     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/5505     Document Type: Short Survey

References (12)

1. Coley, W.B. Contribution to the knowledge of sarcoma. Ann. Surg. 14, 199-220 (1891).
2. Vassalli, P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411 -452 (1992).
3. Walczak, H. et al. Tumoricidal activity of TRAIL in vivo. Nature Med. 5, 157-163 (1999).
4. Smith, C.A., Farrah, T. & Goodwin, R.G. The TNF-receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76, 959-962 (1994).
5. Ashkenazi, A. & Dixit, V.M. Death receptors: Signaling and modulation. Science 281, 1 305-1 308 (1998).
6. Schneider, P. et al. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1-9 (1998).
7. Wiley, S.R. et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682 (1995).
8. Griffith, T.S. & Lynch, D.H. TRAIL: A molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10, 559-563 (1998).
9. Irmler, M. et al. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195 (1997).
10. Pan, G. et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818 (1997).
11. Sheridan, J.P. et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818-821 (1997).
12. Wu, G.S. et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene [letter]. Nature Genet. 17, 141-143 (1997).